Abstract
The Society of Behavioral Medicine (SBM) urges stakeholders to support the National Colorectal Cancer Roundtable’s (NCCRT) initiative 80 % by 2018. Colorectal cancer (CRC) is largely preventable with early detection of pre-cancerous polyps but CRC screening is underutilized, especially among the underserved. In response to low screening rates, this initiative sets an important goal of a population screening rate of 80 % in adults ages 50 and older by the year 2018. It is estimated that this screening rate could prevent more than 20,000 CRC deaths per year within 15 years. The initiative takes a multilevel approach to improving screening rates and includes recommendations for clinicians, health care organizations, insurers, policymakers, and researchers.
Similar content being viewed by others
References
Meester RGS, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015; 121(13): 2281-2285.
American Cancer Society. Colorectal Cancer Facts & Figures 2014-2016. Atlanta: American Cancer Society; 2015.
Subramanian S, Klosterman M, Amonkar M, Hunt T. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004; 38: 536-550.
Ahmed NU, Pelletier V, Winter K, Albatineh AN. Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening. Am J Public Health. 2013; 103(7): e91-e99.
Ananthakrishnan A, Schellhase K, Sparapani R, Laud P, Neuner J. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007; 167(3): 258-264.
Cole AM, Jackson JE, Doescher M. Urban–rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the Centers for Disease Control’s Behavioral Risk Factor Surveillance Study. Cancer Med. 2012; 1(3): 350-356.
James TM. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis. 2006; 16(1): 228-233.
Becker EA, Griffith DM, West BT, Janz NK, Resnicow K, Morris AM. Potential biases introduced by conflating screening and diagnostic testing in colorectal cancer screening surveillance. Cancer Epidemiol Biomarkers Prev. 2015; 24(12): 1850-1854.
Acknowledgments
This manuscript was supported in part by the National Cancer Institute under award number R25CA057699. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors wish to gratefully acknowledge the expert review provided by the Society of Behavioral Medicine’s Health Policy Committee, Health Policy Council, and the Cancer Special Interest Group.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
All procedures were conducted in accordance with ethical standards.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Implications
Practice: Health care institutions should examine their role in improving accessibility, awareness, and efficiency of CRC screening practices.
Policy: Policymakers should prioritize the development and implementation of laws and regulations that support CRC screening including funding mechanisms and quality measurements that include population screening rates and targeting disparities across sociodemographic groups.
Research: Researchers need to examine social determinants of CRC screening to identify points of intervention at societal, community, and family levels that would increase CRC screening rates, particularly in underserved communities.
About this article
Cite this article
Becker, E.A., Buscemi, J., Fitzgibbon, M.L. et al. Society of Behavioral Medicine (SBM) position statement: SBM supports the National Colorectal Cancer Roundtable’s (NCCRT) call to action to reach 80 % colorectal cancer screening rates by 2018. Behav. Med. Pract. Policy Res. 6, 306–308 (2016). https://doi.org/10.1007/s13142-015-0364-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13142-015-0364-6